Concerned about the diversion of opioids, the Ohio Board of Pharmacy has fined Cardinal Health (CAH), one of the largest pharmaceutical wholesalers in the U.S., $5,000 for failing to secure shipments of controlled substances.

A board spokesman explained that the small penalty reflected limits of $2,500 per violation, but that the board took the infraction seriously. “We want all controlled substances secured and not subject to diversion,” he told us. “And want to make sure that Cardinal Health has policies and procedures in place to prevent that problem.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • To make a firm the size of Cardinal pay $5,000 USD, the infamy and abuse of a ‘legitimate’ company! (Wait, did I just observe that I said that? “Oh my stars and little planets ….”)

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy